HighTower Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,140	Closed	-$207K	–	2120
2018 Q1	$207K	Buy	+7,140	New	+$207K	﹤0.01%	1849